title: Significance of left-sided heart disease for the detection of patent foramen ovale by transesophageal contrast echocardiography.
abstract: Detection of patent foramen ovale by contrast echocardiography is based on transient inversion (right atrial pressure higher than left atrial pressure) of the interatrial pressure gradient. Therefore, the presence of left-sided heart disease with potential elevation of left atrial pressure might obscure the diagnosis of patent foramen ovale. Accordingly, 150 patients (88 men, 62 women; mean age 51.7 +/- 15.2 years) were evaluated for a patent foramen ovale by transesophageal contrast echocardiography. Additionally, atrial septal motion during normal respiration and during the Valsalva maneuver was analyzed. Patency of the foramen ovale was observed in 20 (27%) of 74 patients without left-sided heart disease and with previous arterial embolism, in none (0%) of 25 patients with left-sided heart disease and embolism, in 7 (39%) of 18 patients without left-sided heart disease and without embolism and in 3 (9%) of 33 patients with left-sided heart disease and without embolism. The detection rate of patent foramen ovale was lower in patients with than without left-sided heart disease (5% vs. 29%, p = 0.0007) but was similar in patients with and without embolism (20% vs. 19.5%, p = NS). Abnormal atrial septal motion was more frequently observed in patients with left-sided heart disease (p = 0.0003) and was inversely correlated to detection of patent foramen ovale (p = 0.0003). Multivariate analysis revealed an independent association between the absence of left-sided heart disease and the detection of patent foramen ovale (p = 0.0003). These data suggest that in patients with left-sided heart disease, patency of the foramen ovale may be missed even by transesophageal contrast echocardiography.
authors.affiliation: 1st Department of Medicine, University of Vienna, Austria.
authors.forename: P
authors.initials: P
authors.lastname: Siostrzonek
authors.forename: W
authors.initials: W
authors.lastname: Lang
authors.forename: M
authors.initials: M
authors.lastname: Zangeneh
authors.forename: H
authors.initials: H
authors.lastname: Gössinger
authors.forename: A
authors.initials: A
authors.lastname: Stümpflen
authors.forename: G
authors.initials: G
authors.lastname: Rosenmayr
authors.forename: G
authors.initials: G
authors.lastname: Heinz
authors.forename: M
authors.initials: M
authors.lastname: Schwarz
authors.forename: K
authors.initials: K
authors.lastname: Zeiler
authors.forename: H
authors.initials: H
authors.lastname: Mösslacher
mesh_terms: D000328:Adult; D000368:Aged; D016009:Chi-Square Distribution; D003287:Contrast Media; D003937:Diagnosis, Differential; D004452:Echocardiography / Q000295:instrumentation / Q000379:methods* / Q000706:statistics & numerical data; D004617:Embolism / Q000000981:diagnostic imaging / Q000453:epidemiology; D004947:Esophagus; D005260:Female; D005780:Gelatin / Q000031:analogs & derivatives; D006331:Heart Diseases / Q000000981:diagnostic imaging* / Q000453:epidemiology; D006344:Heart Septal Defects, Atrial / Q000000981:diagnostic imaging* / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis; D014636:Valsalva Maneuver; D016277:Ventricular Function, Left
chemical_list: D003287:Contrast Media; D005780:Gelatin; C002803:oxypolygelatine